There are many gangs in the world and there are many areas in which they operate, neither tolerable. But the African continent is suffering the worst of all, you pay with their lives.
most prevalent in Kenya two diseases: AIDS and Tuberculosis.
That is because the country was chosen to experience a new drug developed by the pharmaceutical industry for tuberculosis.
In the film The Constant Gardener / Constant Gardener (2005), which is an adaptation of John Le Carre's book published in 2001, where with a particular view shows the medical practice in developing countries, are reflected in AIDS treatment, as well as studying new treatments for diseases such as TB *.
We demonstrate a reality that perhaps guess, but little understood, and inequality toward African people.
to fight the disease tuberculosis treatment is provided in tablets of a new therapeutic tool called Dypraxa.
Health systems are struggling with the pharmaceutical industry to achieve the production of generic drugs to reduce costs.
In countries such as Namibia, one of the richest in the South West Africa continue to increase AIDS cases, despite the drug companies sell their patented products at prices much lower, they remain inaccessible to the population. Patent in hand is not possible to produce antiretroviral drugs at lower cost to those who could access most affected in those countries. In Africa there are 24.5 million people affected by HIV / AIDS, 71% of world population affected. Are subjected to a double "industrial dictatorship" in which the drug under any circumstances give up the benefits and the increased traffic of goods de imitación. Las redes de tráfico ilegal venden cada vez más en el tercer mundo medicamentos que no son tales, como cápsulas llenas de azúcar que se supone que van a bajar la fiebre de los niños o aliviar los dolores, están a la orden del día y, en muchos casos, producen la muerte de quien los toma pensando que son auténticas.
En palabras de la Directora de la Organización Mundial de la Salud, Margaret Chan, "la salud y los intereses de la propiedad son irreconciliables". Uno de los casos más llamativos es el de la empresa alemana Bayer, una de las empresas farmacéuticas con mayores beneficios del mundo y comprometida con el desarrollo sostenible. Bayer tiene proyectos en varios países, relacionados climate change and air pollution, programs to combat racism, reconstruction, among others. But it is curious that no programs have access to medicines for those most in need, where their activity is the production of them. It has accused the German company to sell unsafe drugs to third world in the 80's, while in Europe and the United States selling more advanced. Only in Hong Kong and Taiwan, more than 100 hemophiliacs contracted HIV * to consume unsafe products (Factor VIII *). Bayer has finished paying the victims the sum of $ 600 million in compensation after years of trials.
In fact, it demands a different treatment for the Third World.
TRIPS international agreements related to the Patent Law, guarantee 20 years of patent medicines.
Back in Doha, capital of Qatar, was claimed by a change or at least a relaxation of these agreements.
While the older drugs are free from patent, new drugs are subject to protection and unaffordable for developing countries and even developed countries. After 11 September, the United States did not hesitate to threaten to produce themselves Bayer Cipro, patented antibiotics against Anthrax, the high price at which the pharmacist refused to sell. In the end, they negotiated the price reduction, and the final consumer tablet has a cost of over $ 4. For the American pocket is not much, but if you move for example to Cuba, where the average monthly wage is U.S. $ s 10, would cost about half the salary.
Ethics is the scientific discipline that studies the correctness and goodness of human behavior. The analysis of the behavior of those involved in the case of drug development does not follow the guidelines of kindness, but the benefit of his own, and that hide the negative results being inimical to their interests. This is because there is no independence between producer and manager of the drug in the country of testing. To be a common benefit, and not properly follow the protocol for marking prior to the completion of the trial, flagrantly violates the ethics of that process.
When an investigation in which people participate, it must satisfy certain basic conditions, which are informed consent and privacy, intimacy and anonymity of the information obtained in the studies. In regard to informed consent, the most important from the ethical point of view is not obtained, but the process you get. This process must have a number of features fundamental, first has to provide sufficient information, which must be understood by the person who will take part in the study, and finally, enter it voluntarily and can leave when you want, without any coercion by the organizer or other members. To carry out the study on Dypraxa, the film is reported not only that the patient is informed of the effects, beneficial or harmful, but also has no choice, as the refuse to take the drug test involves the loss of health care provision. This fact is noted on the card, health where there is a field that is populated with a cross with the initials IC (indicating informed and under), not receiving any information the trial participant.
* Tuberculosis (TB) is a contagious disease caused by various species of mycobacterium , is the only genus of bacteria Mycobacteriaceace. The genus includes pathogens that cause serious diseases in mammals, including tuberculosis and leprosy.
* Hemophilia: A genetic condition that is the inability of blood to clot.
* Factor VIII clotting factors are a group of proteins responsible for activating the clotting process. There are identified 13 factors, Factor I, II, III, ... ... ... XIII.
0 comments:
Post a Comment